Antifungal drug developer F2G Ltd has appointed distinguished research scientist John Rex to the position of...
Up to date
Appointments
At the beginning of October, Isabel De Paoli assumed the position of Chief Strategy Officer at German...
In order to prepare for the start of Phase III trials with its lead drug candidate Nefecon, Pharmalink AB has...
Copenhagen-based Symphogen is losing its long-time CEO Kirsten Drejer, who co-founded the Danish antibody...
Epidarex Capital-backed respiratory disease start-up Enterprise Therapeutics has named biotech entrepreneur...
Confo Therapeutics wants to metamorphose from a tech company to a drug discovery company, and it has hired...